AYTU BIOPHARMA, INC Increase (Decrease) in Accounts and Notes Receivable
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Accounts and Notes Receivable of $1.35 million for the 6-month period ending 2019-12-31, per its 10-Q filed 2020-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable · last filed 2020-02-14
- AYTU BIOPHARMA, INC increase (decrease) in accounts and notes receivable for the quarter ending 2019-12-31 was $350.00K.
- AYTU BIOPHARMA, INC increase (decrease) in accounts and notes receivable for the quarter ending 2019-09-30 was $1.00M.
- AYTU BIOPHARMA, INC increase (decrease) in accounts and notes receivable for the quarter ending 2018-12-31 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in accounts and notes receivable for the quarter ending 2018-09-30 was $0.00.
| Period end | Increase (Decrease) in Accounts and Notes Receivable 3 month | Increase (Decrease) in Accounts and Notes Receivable 6 month |
|---|---|---|
| 2019-12-31 | $350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $1.35M 10-Q · filed 2020-02-14 |
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | $0.00 10-Q · filed 2020-02-14 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |